Does evidence suggest that the use of inhaled corticosteroids (ICS) in COPD increases the risk of pneumonia?
Abstract
Evidence indicates inhaled corticosteroids in COPD are linked to an increased risk of pneumonia, with different formulations and disease severities potentially modifying the risk.
Fields of Study & Subjects
Chronic Obstructive Pulmonary Disease (COPD) Research
Inhalation and Respiratory Drug Delivery
Asthma and respiratory diseases
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 4 January 2026